论文部分内容阅读
已知慢性肾小球肾炎(XΓH)的治疗迄今仍是一个十分棘手的问题,尤其是伴高血压、肾病综合征(HC)的患者。XΓH的发生机制与免疫炎症有关。XΓH患者往往伴有高凝状态、蛋白尿、肾功能不全和微血管床损害。XΓH常用免疫抑制剂(糖皮质激素、细胞毒剂)、抗凝剂(肝素)、降血压药和利尿剂等,这些药物不仅有一定的副作用,而且长期使用还有发生严重并发症的危险。为了寻找新的治疗方法,基于低能量氦氖激光((?))的生物刺激效应,作者首次将(?)用于治疗XΓH16例(男13例和女3例),年龄19～68岁。
The treatment of known chronic glomerulonephritis (XΓH) is by now still a very troublesome problem, especially in patients with hypertension and nephrotic syndrome (HC). The mechanism of XΓH is related to immune inflammation. XΓH patients are often associated with hypercoagulable state, proteinuria, renal insufficiency and microvascular damage. XΓH commonly used immunosuppressants (glucocorticoids, cytotoxic agents), anticoagulants (heparin), antihypertensive drugs and diuretics, these drugs not only have some side effects, but also the long-term use and the risk of serious complications. In order to find a new treatment method, based on the bio-stimulating effect of low-energy helium-neon laser (?), The authors first (?) Used to treat X? H16 cases (13 males and 3 females), aged 19 to 68 years.